CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-03 | Attar Eyal C. CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +364,000 | 364,000 | ||
| 2025-02-03 | Attar Eyal C. CHIEF MEDICAL OFFICER | Returned to the company · Employee Stock Option (right to buy) | −109,000 | 0 | ||
| 2025-02-03 | Attar Eyal C. CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +109,000 | 109,000 | ||
| 2025-02-03 | Attar Eyal C. CHIEF MEDICAL OFFICER | Returned to the company · Employee Stock Option (right to buy) | −125,000 | 0 | ||
| 2025-02-03 | Attar Eyal C. CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2025-02-03 | Attar Eyal C. CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +315,000 | 315,000 | ||
| 2025-02-03 | Choi Han Wook Chief Financial Officer | Grant or award | +52,500 | 52,500 | ||
| 2025-02-03 | Choi Han Wook Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +315,000 | 315,000 | ||
| 2025-01-06 | Kalir Erez Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-12-30 | Reprogrammed Interchange LLC 10% owner | Purchase | +38,974,101 | 38,974,101 | ||
| 2024-12-30 | Reprogrammed Interchange LLC 10% owner | Purchase · Warrant (Right to Buy) | +48,717,626 | 48,717,626 | ||
| 2024-12-30 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award | +16,897,159 | 37,820,713 | ||
| 2024-12-30 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Warrant (Right to Buy) | +21,121,449 | 21,121,449 | ||
| 2024-12-27 | Attar Eyal C. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −10,334 | $1.25 | $13K | 81,439 |
| 2024-11-06 | Quinlan Amy Vice President of Finance | Shares withheld for taxes | −206 | $0.86 | $177 | 50,312 |
| 2024-11-06 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −875 | $0.86 | $753 | 169,935 |
| 2024-11-06 | Attar Eyal C. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −999 | $0.86 | $859 | 91,773 |
| 2024-11-06 | ANG ROBERT PRESIDENT AND CEO | Shares withheld for taxes | −2,361 | $0.86 | $2K | 787,487 |
| 2024-11-01 | Quinlan Amy Vice President of Finance | Shares withheld for taxes | −343 | $0.80 | $274 | 50,518 |
| 2024-11-01 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −986 | $0.80 | $789 | 170,810 |
Page 10 of 18 · 344 trades